Excel Scientific (Vance Street Capital) Acquires Innovize
November 30, 2022
Vance Street Capital has completed the acquisition of Innovize, LLC, with Innovize joining Excel Scientific LLC (a platform Vance Street partnered with in 2020) to create a medical and life sciences manufacturing platform. The deal brings complementary materials-conversion and complex manufacturing capabilities for diagnostics, wearables and other MedTech end markets; Innovize's founders John Ledy and Dave Jessen will continue to support the business.
- Buyers
- Vance Street Capital LLC, Excel Scientific LLC
- Targets
- Innovize, LLC
- Sellers
- John Ledy, Dave Jessen
- Platforms
- Excel Scientific LLC
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Vance Street Capital Acquires Excel Scientific
January 12, 2021
Medical Devices
Los Angeles-based private equity firm Vance Street Capital acquired Excel Scientific, a Victorville, California manufacturer of microplate sealing films and foils used by life science, biotech, pharmaceutical and diagnostic laboratories. Founder Bambi Lyn Cahilly retains an ownership stake; terms were not disclosed and Vance Street plans to invest in growth and product innovation across life-science end markets.
-
Innovize and Excel Scientific (Vance Street Capital) Acquire Zenith Adhesive Components
April 3, 2025
Medical Devices
Vance Street Capital’s portfolio companies Innovize and Excel Scientific have acquired Zenith Adhesive Components (ZAC), a contract manufacturer based in Athlone, Ireland. The acquisition expands the platform’s adhesive and film-based manufacturing capabilities for medical, life science and high-technology end markets and adds regional capacity to better serve customers in North America and Europe.
-
Vance Street Capital Acquires Injectech and Forms VSC Medical Molding Platform
November 21, 2025
Medical Devices
Vance Street Capital has acquired Injectech from The West Group and added it to its newly formed VSC Medical Molding platform, expanding the platform's precision injection-molding and single-use fluid management capabilities for medical device, life science and bioprocessing customers. Injectech, headquartered in Fort Collins, Colorado, will operate alongside Resenex under the VSC Medical Molding platform to broaden component offerings and custom manufacturing capabilities.
-
Vance Street Capital Acquires Majority Stake in Wytech Industries
November 10, 2020
Medical Devices
Los Angeles-based private equity firm Vance Street Capital acquired Wytech Industries, a Rahway, New Jersey manufacturer of specialty core wires and precision tube-based components for interventional medical devices. The Casalino family (founders) retain an ownership stake alongside Vance Street; terms were not disclosed. The deal represents Vance Street's first platform investment from Fund III and a strategic entry into a medical-device component manufacturing platform.
-
Vance Street Capital Acquires Mountain Manufacturing Technologies (Add-on to Wytech Industries)
October 13, 2022
Medical Devices
Los Angeles-based private equity firm Vance Street Capital acquired Mountain Manufacturing Technologies, a Lino Lakes, Minnesota contract manufacturer of precision mandrels and machined components for medical devices. The deal will complement Vance Street's existing portfolio company Wytech Industries by expanding mandrel capabilities and supporting growth in interventional and advanced surgical markets.
-
Flourish Research / NMS Capital Recapitalize Excel Medical Clinical Trials
October 14, 2021
Healthcare Services
NMS Capital portfolio company Flourish Research partnered with Excel Medical Clinical Trials in a recapitalization. The Boca Raton, Florida-based clinical research site, founded by Dr. Seth Baum and focused on cardiology indications, will join Flourish's site network to expand the platform's geographic footprint and therapeutic capabilities; terms were not disclosed and management will remain in place.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.